title: Medications for dry eye syndrome: a drug-therapy review.
abstract: Early interventions were palliative, attempting to replace water lost from the tear film. Today, therapy is directed at the underlying inflammation, a recognized component of dry eye syndrome, and at the resulting progressive changes to the ocular surface. This approach offers promise of lasting relief to patients with moderate to severe symptoms.
authors.affiliation: Weill School of Medicine, Cornell University, USA.
authors.forename: Henry D
authors.initials: HD
authors.lastname: Perry
authors.forename: Eric D
authors.initials: ED
authors.lastname: Donnenfeld
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016568:Drugs, Generic; D006801:Humans; D007249:Inflammation; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy* / Q000473:pathology; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D013666:Tears / Q000378:metabolism; D014481:United States
chemical_list: D000305:Adrenal Cortex Hormones; D016568:Drugs, Generic; D009883:Ophthalmic Solutions; D016572:Cyclosporine